BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gábriel R, Pöstyéni E, Dénes V. Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin. Front Neurosci 2019;13:1031. [PMID: 31649495 DOI: 10.3389/fnins.2019.01031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Coskuner-weber O, Mirzanli O, Uversky VN. Intrinsically disordered proteins and proteins with intrinsically disordered regions in neurodegenerative diseases. Biophys Rev. [DOI: 10.1007/s12551-022-00968-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kiss P, Farkas J, Kovacs K, Gaal V, Biro Z, Szabo A, Atlasz T, Bosnyak I, Toth G, Tamas A, Reglodi D. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) in corneal epithelial regeneration and signal transduction in rats. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10405-1] [Reference Citation Analysis]
3 Lu P, Shi Y, Ye D, Lu X, Tang X, Cheng L, Xu Y, Huang J. Intravitreal Injection of PACAP Attenuates Acute Ocular Hypertension-Induced Retinal Injury Via Anti-Apoptosis and Anti-Inflammation in Mice. Invest Ophthalmol Vis Sci 2022;63:18. [PMID: 35293951 DOI: 10.1167/iovs.63.3.18] [Reference Citation Analysis]
4 Pöstyéni E, Ganczer A, Kovács-Valasek A, Gabriel R. Relevance of Peptide Homeostasis in Metabolic Retinal Degenerative Disorders: Curative Potential in Genetically Modified Mice. Front Pharmacol 2021;12:808315. [PMID: 35095518 DOI: 10.3389/fphar.2021.808315] [Reference Citation Analysis]
5 Karpiesiuk A, Palus K. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Physiological and Pathological Processes within the Gastrointestinal Tract: A Review. Int J Mol Sci 2021;22:8682. [PMID: 34445388 DOI: 10.3390/ijms22168682] [Reference Citation Analysis]
6 Perlikowska R. Whether short peptides are good candidates for future neuroprotective therapeutics? Peptides 2021;140:170528. [PMID: 33716091 DOI: 10.1016/j.peptides.2021.170528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pöstyéni E, Kovács-Valasek A, Dénes V, Mester A, Sétáló G Jr, Gábriel R. PACAP for Retinal Health: Model for Cellular Aging and Rescue. Int J Mol Sci 2021;22:E444. [PMID: 33466261 DOI: 10.3390/ijms22010444] [Reference Citation Analysis]
8 D’amico AG, Maugeri G, Musumeci G, Reglodi D, D’agata V. PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy. J Mol Neurosci 2021;71:1525-35. [DOI: 10.1007/s12031-020-01769-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
9 Fang Y, Ren R, Shi H, Huang L, Lenahan C, Lu Q, Tang L, Huang Y, Tang J, Zhang J, Zhang JH. Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke. Aging Dis 2020;11:1496-512. [PMID: 33269103 DOI: 10.14336/AD.2020.0626] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Kovacs AK, Atlasz T, Werling D, Szabo E, Reglodi D, Toth GK. Stability Test of PACAP in Eye Drops. J Mol Neurosci 2021;71:1567-74. [PMID: 32323126 DOI: 10.1007/s12031-020-01532-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]